Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (111-120 of 247) with videos related to

Pageof 25
Sort By:
Molecular Immunology|November 7, 2012
Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodiesSteve Rockman, Sarina Camuglia, Kirsten Vandenberg, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Quantitation of Polymyxin-Lipopolysaccharide Interactions Using an Image-Based Fluorescent ProbeMitchell P McInerney, Kade D Roberts, Philip E Thompson, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and ModelingRajbharan Yadav, Jürgen B Bulitta, Elena K Schneider, et al.
BMC Infectious Diseases|October 13, 2018
Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisitionAgnes Loo Yee Cheah, Allen C Cheng, Denis Spelman, et al.
The Lancet. Infectious Diseases|August 26, 2006
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infectionsJian Li, Roger L Nation, John D Turnidge, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection modelsRajesh V Dudhani, John D Turnidge, Kingsley Coulthard, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?Mohammad A K Azad, Bo Yun, Kade D Roberts, et al.
Scientific Reports|March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Journal of Natural Products|January 13, 2017
Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in RatsSivashangarie Sivanesan, Kade Roberts, Jiping Wang, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control AlgorithmElizabeth A Lakota, Cornelia B Landersdorfer, Roger L Nation, et al.
Pageof 25

Showing results (111-120 of 247) with videos related to

Sort By:
Pageof 25
Molecular Immunology|November 7, 2012
Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodiesSteve Rockman, Sarina Camuglia, Kirsten Vandenberg, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Quantitation of Polymyxin-Lipopolysaccharide Interactions Using an Image-Based Fluorescent ProbeMitchell P McInerney, Kade D Roberts, Philip E Thompson, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and ModelingRajbharan Yadav, Jürgen B Bulitta, Elena K Schneider, et al.
BMC Infectious Diseases|October 13, 2018
Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisitionAgnes Loo Yee Cheah, Allen C Cheng, Denis Spelman, et al.
The Lancet. Infectious Diseases|August 26, 2006
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infectionsJian Li, Roger L Nation, John D Turnidge, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2009
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection modelsRajesh V Dudhani, John D Turnidge, Kingsley Coulthard, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Measuring polymyxin uptake by renal tubular cells: is BODIPY-polymyxin B an appropriate probe?Mohammad A K Azad, Bo Yun, Kade D Roberts, et al.
Scientific Reports|March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Journal of Natural Products|January 13, 2017
Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in RatsSivashangarie Sivanesan, Kade Roberts, Jiping Wang, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control AlgorithmElizabeth A Lakota, Cornelia B Landersdorfer, Roger L Nation, et al.
Pageof 25